Skip to content

Pharma company investors call for clinical trials transparency

In an unprecedented move, a group of 85 asset managers and pension funds is teaming with a U.K. non-profit campaign (AllTrials campaign) to pressure pharmaceutical companies to disclose clinical trial data (i.e. get clinical trials registered and results reported). The investors represent more than €3.5 trillion in assets.

Read more in the Financial Times and Wall Street Journal.

Leave a Reply

%d bloggers like this: